Medicus International has been successfully developing global communications for 30 years.
Medicus International has been successfully delivering global communications for 30 years. Our philosophy is to develop inspired strategic solutions through an understanding of market opportunity and trends, product differentiation and required target audience reach. This has established us as experts in defining global communications strategies that deliver brand success.
We believe that we have pioneered the first truly successful approach to delivering marketing solutions to international pharmaceutical clients. With dedicated client service teams based in London and New York, we have extensive experience in supporting pre-launch, launch and post-launch phases in all major therapy areas. These encompass allergy, CV disease, CNS disease (including schizophrenia and depression), diabetes, fertility, gastroenterology, infectious diseases (including HIV), oncology, osteoporosis, pain, respiratory, rheumatology, and transplantation.
Our core services include:
As part of the Publicis Healthcare Communications Group, Medicus International is supported by the largest worldwide healthcare network, including Medicus and Discovery offices and the Saatchi & Saatchi Healthcare Group.
For further details contact
Peneli Oliver, Managing Director
peneli.oliver@medicusgroup.com
Jane Smith, Director of Client Services
jane.smith@medicusgroup.com
Or visit www.medicus-international.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.